Manufacturer record
Salus Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Salus Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between February 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
14 records linked to Salus Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ondansetron Orally Disntagrating Tablets IP | SPT252281Mfg 2025-10 · Exp 2027-09 | The sample has been declared as NSQ as it does not conform to IP standard with respect to Test for DisintegrationDisintegration | RDTL. Bellary KarnatakaState lab | Jul 2026 |
| Methotrexate Tablets IP 2.5mg | SPOT260026BMfg 2026-02 · Exp 2028-01 | MisbrandedMisbranded | Andmand NicobarState lab | Jun 2026 |
| Albendazole Tablets IP 400 mg. (Macbi-400) | SPT241854Mfg 2024-09 · Exp 2026-08 | Dissolution of AlbendazoleDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Amlodipine Besylate Tablets I.P. 2.5 mg (AMLODOSE ? 2.5 ) | SPT240321Mfg 2024-02 · Exp 2026-01 | The Sample does not conform to standard in respect of the test for Assay & Uniformity of ContentAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab | May 2025 |
| GLIMEPIRIDE TABLETS IP (GLIMP-1) | SPT240261Mfg 2024-02 · Exp 2026-01 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Dec 2024 |
| OMEPRAZOLE & DOMPERIDONE CAPSULES (REMIZOLE-D) | SPC230578 CMfg 2023-03 · Exp 2025-02 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Zinc Sulphate Tablets IP. (Saluzinc- 20) | SPT230376Mfg 2023-02 · Exp 2025-01 | DisintegrationDisintegration | RDTL GuwahatiState lab | Mar 2024 |
| SPIRONOLACTONE TABLETS IP (SPIRNORAV-100) | SPT221635Mfg 2022-07 · Exp 2024-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2023 |
| Clorin Capsules (Aspirin & Clopidogrel Capsules) | SPC221847Mfg 2022-08 · Exp 2024-07 | Assay of Aspirin & Dissolution of AspirinAssay | CDL KolkataCDSCO lab | Jun 2023 |
| Astrizo-2.5 Tablets (Letrozole Tablets I.P. 2.5 mg) | SPT220701Mfg 2022-03 · Exp 2024-02 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2023 |
| Cantop-40 Tablets (Pantoprazole Tablets IP) | SPT170513DMfg 2022-04 · Exp 2023-09 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2022 |
| Fexofenadine Hydrochloride Tablets IP 180 mg (Medrofex-180 Tablets) | SPT190012AMfg 2019-01 · Exp 2020-12 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Dec 2019 |
| Medtoin (Phenytoin Sodium Tablets I.P.) | SPT190048AMfg 2019-01 · Exp 2020-12 | Description and DisintegrationDescription | CDL KolkataCDSCO lab | Nov 2019 |
| Cefixime & Lactic Acid Bacillus Tablets (Tixi-200 LB) | FSP17159AMfg 2017-10 · Exp 2019-09 | Uniformity of WeightUniformity of weight/content | Drugs Control Department, MizoramCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.